Selective dopamine-1 receptor agonist augments regional myocardial blood flow: Comparison of fenoldopam and dopamine
- 31 August 1992
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 124 (2) , 418-423
- https://doi.org/10.1016/0002-8703(92)90607-w
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.Circulation, 1990
- Comparison of Dopamine and Fenoldopam Effects on Renal Blood Flow and Prostacyclin Excretion in Normal and Essential Hypertensive SubjectsJournal of Clinical Endocrinology & Metabolism, 1989
- Cardiovascular and renal hemodynamic effects of intravenous infusions of the selective DA1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine.Circulation, 1988
- Evaluation of nonradioactive, colored microspheres for measurement of regional myocardial blood flow in dogs.Circulation, 1988
- Intravenous fenoldopam in heart failure: Comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprussideAmerican Heart Journal, 1988
- Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.Circulation, 1987
- Hemodynamic effects of an oral dopamine receptor agonist (fenoldopam) in patients with congestive heart failureJournal of the American College of Cardiology, 1985
- Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction.Circulation, 1976
- Total and Regional Myocardial Blood Flow Measurements with 25µ, 15µ, 9µ, and Filtered 1-10µ Diameter Microspheres and Antipyrine in Dogs and SheepCirculation Research, 1974
- Effect of dopamine on coronary vascular resistance and myocardial functionCardiovascular Research, 1971